Printer Friendly

Bacterial flora in digestive disease; focus on rifaximin.


Bacterial flora in digestive disease; focus on rifaximin.

Ed. by C. Scarpignato and A. Lanas.

S. Karger, AG


253 pages




Drawn from a workshop attended by Italian and Spanish gastroenterologists, this collection considers the role of the poorly absorbed antibiotic, rifaximin, in gastroenterological conditions while describing the pathogenesis and therapy of several conditions related to the microbiota of the gut. The 15 papers assess current treatment options for bowel disorders, colonic diverticular disease, inflammatory bowel disease, hepatic encephalopathy, traveler's diarrhea, and Helicobacter pylori infection. A few color photographs are provided. Originally published as Digestion, v.73, suppl.1, 2006.

([c]20062005 Book News, Inc., Portland, OR)
COPYRIGHT 2006 Book News, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:SciTech Book News
Article Type:Book Review
Date:Sep 1, 2006
Previous Article:The pathology of democracy; a letter to Bernard Accoyer and to enlightened opinion.
Next Article:Handbook on neurovascular ultrasound.

Related Articles
Lactic Acid Bacteria.
Probiotics and prebiotics: where are we going?
Human Body Systems.
Rifaximin, a poorly absorbed antibiotic; pharmacology and clinical use.
Bacterial wilt disease and the ralstonia solanacearum species complex.
The Good Digestion Guide.
Annual review of biochemistry, vol. 76, 2007.
Handbook of Zoonoses: Identification and Prevention.
Genetic vectors research focus.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters